Fundraising Fox

Kevin Johnson

Investor

Co-founder & Senior Advisor at Medicxi

Hertfordshire, UK

About

Co-founder and Senior Advisor at Medicxi who previously spent 13 years as a Partner at Index Ventures, where he originated its first asset-centric investment and led Medicxi's investment in Impact Biomedicines. Earlier he was Research Director and CTO at Cambridge Antibody Technology, contributing to antibodies now marketed as Humira and Benlysta.

LinkedIn ↗X / Twitter ↗
Latest on 𝕏

Kevin Johnson @medicxikevin

It is indeed a brilliant achievement Gil. Bravo Kate, I do believe the best measure of a persons worth is whether you’ve made the world a better place @mavenclinic https://t.co/6vrKzITwxE

Aug 20, 2021 · ♥ 2

Kevin Johnson @medicxikevin

To all the people involved with the Oxford AZ vaccine effort, please don't be disheartened by all this misinformation and shameful political nonsense. You're leading the way out of this pandemic and your colleagues in the industry are proud of you.

Apr 3, 2021 · ♥ 661 · ⇄ 77

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Medicxi VenturesGeneral Partnercurrent2016 — presentLondon Area, United Kingdom
  2. Index VenturesVenture Partner2010 — 2016
  3. Index VenturesVenture Advisor2003 — 2010
  4. PanGenetics BVCEO2005 — 2010
  5. Ash Biotech ConsultingOwner2003 — 2010
  6. Cambridge Antibody TechnologyChief Technology Officer1990 — 2003

Education

  1. University of CambridgePhD, Molecular Parasitology1982 — 1986
  2. The University of EdinburghBSc (hons), Molecular Biology1978 — 1982
  3. University of MelbournePost Doc, Vaccines1986 — 1988

Skills & more

Vaccines11Technology Transfer36Drug Development63Lifesciences19Biotechnology51Start-ups21Venture Capital29R&D13Biochemistry9Drug Discovery16Antibodies9Molecular Biology6
+12 moreClinical DevelopmentImmunologyBiopharmaceuticalsGenomicsCellBioinformaticsMedical DevicesPatentsProtein ChemistryCommercializationCorporate DevelopmentLicensing

From Kevin's professional profile.

Same school

Also attended University of Cambridge630

Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures

+ 624 more

Also attended The University of Edinburgh144

Sofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalEmily PawlakVice President at Volition CapitalTom FergusonFounder and Managing Partner at BURNT ISLAND VENTURESJess LynchGeneral Partner at FoundersEdge

+ 138 more

Also attended University of Melbourne193

Esther GilmoreGlobal Head of the Client Team at Generation Investment ManagementMark MillsClient Team Member at Generation Investment ManagementPaulInvestor at Square Peg CapitalPaul BassatCo-Founder & Partner at Square Peg CapitalDan KrasnosteinPartner at Square Peg CapitalLeila LeePartner & Head of Distribution at Square Peg Capital

+ 187 more

Shared employers

Also worked at Index Ventures132

Danny RimerPartner at Index VenturesAdrianna MaInvestor at Index VenturesAli Fisher SweetInvestor at Index VenturesAna AndreescuInvestor at Index VenturesAndré DuboisInvestor at Index VenturesAvron MarcusInvestor at Index Ventures

+ 126 more

Also worked at PanGenetics BV1

Shelley MargetsonManaging Partner at V-Bio Ventures

Also worked at Cambridge Antibody Technology1

Celia HartGeneral Partner at Supernova Invest

Investments

Led

Impact Biomedicines

Board seats

Crescendo BiologicsLevicept

Investor

PanGenetics

Per the firm's website.

Colleagues at Medicxi

Andrew Jeanne
Investor at Medicxi
Ben Perry
Investor at Medicxi
Charles Grummitt
Investor at Medicxi
Charline Gesbert
Investor at Medicxi
David Grainger
Investor at Medicxi
Florence Liaigre
Investor at Medicxi
Francesco De Rubertis
Investor at Medicxi
Francois Prinsloo
Investor at Medicxi